INM
InMed Pharmaceuticals Inc.
Key Financials
Gross Profit
$1.7M
↑ 55.0%
Net Income
$-8162133
↓ 6.3%
Operating Income
$-7947622
↑ 57.3%
Total Liabilities
$2.1M
↓ 18.0%
Revenue
$4.9M
↑ 7.5%
EPS (Diluted)
$-8.36
↓ 727.7%
Cash & Equivalents
$11.1M
↑ 68.5%
Total Assets
$15.6M
↑ 31.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INM |
| Company Name | InMed Pharmaceuticals Inc. |
| CIK | 1728328 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | A1 |
| Phone | (604) 669-7207 |